This page contains brief information about inotuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Inotuzumab ozogamicin is approved to treat:
- B-cell acute lymphoblastic leukemia (ALL) that has relapsed or is refractory (does not respond to treatment).
Inotuzumab ozogamicin is also being studied in the treatment of other types of cancer.
More About Inotuzumab Ozogamicin
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Inotuzumab Ozogamicin - Check for trials from NCI's list of cancer clinical trials now accepting patients.